Vericel (VCEL) Accounts Payables (2010 - 2026)
Vericel (VCEL) reported Accounts Payables of $19.0 million for Q1 2026, up 13.48% on a YoY basis from $16.8 million in Q1 2025, and up 20.1% sequentially from $15.8 million in Q4 2025.
Vericel (VCEL) Accounts Payables (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of Accounts Payables data on file, last reported at $19.0 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables rose 13.48% year-over-year to $19.0 million; the trailing twelve-month figure through Mar 2026 stood at $19.0 million (up 13.48% YoY), and the FY2025 full-year result was $15.8 million, down 33.63% from the prior year.
- Accounts Payables improved to $19.0 million in Q1 2026, from $15.8 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $25.2 million in Q2 2024 to a low of $7.8 million in Q1 2022.
- A 5-year average of $16.2 million and a median of $15.8 million in 2025 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables surged 87.78% in 2022 and sank 49.01% in 2025, its largest moves.
- Tracing VCEL's Accounts Payables over 5 years: stood at $16.9 million in 2022, then surged by 32.0% to $22.3 million in 2023, then rose by 6.72% to $23.8 million in 2024, then plunged by 33.63% to $15.8 million in 2025, then increased by 20.1% to $19.0 million in 2026.
- Business Quant data shows VCEL's Accounts Payables at $19.0 million in Q1 2026, $15.8 million in Q4 2025, and $15.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 19.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.01 Mn |
| Dec 31, 2025 | 15.83 Mn |
| Sep 30, 2025 | 15.34 Mn |
| Jun 30, 2025 | 12.86 Mn |
| Mar 31, 2025 | 16.75 Mn |
| Dec 31, 2024 | 23.85 Mn |
| Sep 30, 2024 | 20.88 Mn |
| Jun 30, 2024 | 25.22 Mn |
| Mar 31, 2024 | 19.43 Mn |
| Dec 31, 2023 | 22.35 Mn |
| Sep 30, 2023 | 15.05 Mn |
| Jun 30, 2023 | 14.40 Mn |
| Mar 31, 2023 | 11.13 Mn |
| Dec 31, 2022 | 16.93 Mn |
| Sep 30, 2022 | 8.11 Mn |
| Jun 30, 2022 | 9.68 Mn |
| Mar 31, 2022 | 7.75 Mn |
| Dec 31, 2021 | 9.02 Mn |
| Sep 30, 2021 | 5.58 Mn |
| Jun 30, 2021 | 8.13 Mn |